In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages
Authors:
- Amelia BarilliABAmelia Barilli
- Bianca Maria RotoliBRBianca Maria Rotoli
- Rossana VisigalliRVRossana Visigalli
- Ovidio BussolatiOBOvidio Bussolati
- Gian C GazzolaGGGian C Gazzola
- Zamir KadijaZKZamir Kadija
- Giuseppe RodiGRGiuseppe Rodi
- Francesca MarianiFMFrancesca Mariani
- Maria Lorena RuzzaMRMaria Lorena Ruzza
- Maurizio LuisettiMLMaurizio Luisetti
- Valeria Dall'AstaVDValeria Dall'Asta
Open Access
- 26 November 2010
- journal article
- case report
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 5 (1) , 32
Abstract
Background: In the recessive aminoaciduria Lysinuric Protein Intolerance (LPI), mutations of SLC7A7/y+LAT1 impair system y+L transport activity for cationic amino acids. A severe complication of LPI is a form of Pulmonary Alveolar Proteinosis (PAP), in which alveolar spaces are filled with lipoproteinaceous material because of the impaired surfactant clearance by resident macrophages. The pathogenesis of LPI-associated PAP remains still obscure. The present study investigates for the first time the expression and function of y+LAT1 in monocytes and macrophages isolated from a patient affected by LPI-associated PAP. A comparison with mesenchymal cells from the same subject has been also performed. Methods: Monocytes from peripheral blood were isolated from a 21-year-old patient with LPI. Alveolar macrophages and fibroblastic-like mesenchymal cells were obtained from a whole lung lavage (WLL) performed on the same patient. System y+L activity was determined measuring the 1-min uptake of [3H]-arginine under discriminating conditions. Gene expression was evaluated through qRT-PCR. Results: We have found that: 1) system y+L activity is markedly lowered in monocytes and alveolar macrophages from the LPI patient, because of the prevailing expression of SLC7A7/y+LAT1 in these cells; 2) on the contrary, fibroblasts isolated from the same patient do not display the transport defect due to compensation by the SLC7A6/y+LAT2 isoform; 3) in both normal and LPI monocytes, GM-CSF induces the expression of SLC7A7, suggesting that the gene is a target of the cytokine; 4) GM-CSF-induced differentiation of LPI monocytes is comparable to that of normal cells, demonstrating that GM-CSF signalling is unaltered; 5) general and respiratory conditions of the patient, along with PAP-associated parameters, markedly improved after GM-CSF therapy through aerosolization. Conclusions: Monocytes and macrophages, but not fibroblasts, derived from a LPI patient clearly display the defect in system y+L-mediated arginine transport. The different transport phenotypes are referable to the relative levels of expression of SLC7A7 and SLC7A6. Moreover, the expression of SLC7A7 is regulated by GM-CSF in monocytes, pointing to a role of y+LAT1 in the pathogenesis of LPI associated PAP.Keywords
This publication has 39 references indexed in Scilit:
- SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intoleranceOrphanet Journal of Rare Diseases, 2009
- Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophagesCurrent Opinion in Immunology, 2009
- Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case reportOrphanet Journal of Rare Diseases, 2007
- Lysosomal Phospholipase A2 and PhospholipidosisMolecular and Cellular Biology, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intoleranceThe Journal of Pediatrics, 2004
- Increased NO production in lysinuric protein intoleranceJournal of Inherited Metabolic Disease, 2004
- Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical courseThe Journal of Pediatrics, 1995
- Role of haematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intoleranceEuropean Journal of Pediatrics, 1993
- A difficult diagnosis of lysinuric protein intolerance: association with glucose‐6‐phosphate dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1991